47 related articles for article (PubMed ID: 26045747)
1. Notch Pathway Is Activated via Genetic and Epigenetic Alterations and Is a Therapeutic Target in Clear Cell Renal Cancer.
Bhagat TD; Zou Y; Huang S; Park J; Palmer MB; Hu C; Li W; Shenoy N; Giricz O; Choudhary G; Yu Y; Ko YA; Izquierdo MC; Park AS; Vallumsetla N; Laurence R; Lopez R; Suzuki M; Pullman J; Kaner J; Gartrell B; Hakimi AA; Greally JM; Patel B; Benhadji K; Pradhan K; Verma A; Susztak K
J Biol Chem; 2017 Jan; 292(3):837-846. PubMed ID: 27909050
[TBL] [Abstract][Full Text] [Related]
2. Discovery of novel 1H-benzo[d]imidazole-4,7-dione based transglutaminase 2 inhibitors as p53 stabilizing anticancer agents in renal cell carcinoma.
Kim GR; Kang JH; Kim HJ; Im E; Bae J; Kwon WS; Rha SY; Chung HC; Cho EY; Kim SY; Kim YC
Bioorg Chem; 2024 Feb; 143():107061. PubMed ID: 38154386
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B Virus X Protein (HBx) Is Responsible for Resistance to Targeted Therapies in Hepatocellular Carcinoma: Ex Vivo Culture Evidence.
Huang P; Zhuang B; Zhang H; Yan H; Xiao Z; Li W; Zhang J; Tang Q; Hu K; Koeffler HP; Wang J; Yin D
Clin Cancer Res; 2015 Oct; 21(19):4420-30. PubMed ID: 26059188
[TBL] [Abstract][Full Text] [Related]
4. Combination of metformin and valproic acid synergistically induces cell cycle arrest and apoptosis in clear cell renal cell carcinoma.
Zhang X; Zhang X; Huang T; Geng J; Liu M; Zheng J
Int J Clin Exp Pathol; 2015; 8(3):2823-8. PubMed ID: 26045790
[TBL] [Abstract][Full Text] [Related]
5. Combination treatment of all-trans retinoic acid (ATRA) and γ-secretase inhibitor (DAPT) cause growth inhibition and apoptosis induction in the human gastric cancer cell line.
Patrad E; Niapour A; Farassati F; Amani M
Cytotechnology; 2018 Apr; 70(2):865-877. PubMed ID: 29417442
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of CKAP4 is Associated with Poor Prognosis in Clear Cell Renal Cell Carcinoma and Functions via Cyclin B Signaling.
Sun CM; Geng J; Yan Y; Yao X; Liu M
J Cancer; 2017; 8(19):4018-4026. PubMed ID: 29187877
[No Abstract] [Full Text] [Related]
7. Inhibition of γ-secretase by retinoic acid chalcone (RAC) induces G2/M arrest and triggers apoptosis in renal cell carcinoma.
Li QC; Li HJ; Liu S; Liang Y; Wang X; Cui L
Int J Clin Exp Pathol; 2015; 8(3):2400-7. PubMed ID: 26045747
[TBL] [Abstract][Full Text] [Related]
8. Cantharidin induces G2/M arrest and triggers apoptosis in renal cell carcinoma.
Ren Y; Zhang SW; Xie ZH; Xu XM; Chen LL; Lou ZG; Weng GB; Yao XP
Mol Med Rep; 2016 Dec; 14(6):5614-5618. PubMed ID: 27878266
[TBL] [Abstract][Full Text] [Related]
9. Antiproliferative effects of γ-secretase inhibitor, a Notch signalling inhibitor, in multiple myeloma cells and its molecular mechanism of action.
Hu J; Zhu X; Lu Q
J Int Med Res; 2013 Aug; 41(4):1017-26. PubMed ID: 23839278
[TBL] [Abstract][Full Text] [Related]
10. Decitabine induces G2/M cell cycle arrest by suppressing p38/NF-κB signaling in human renal clear cell carcinoma.
Shang D; Han T; Xu X; Liu Y
Int J Clin Exp Pathol; 2015; 8(9):11140-8. PubMed ID: 26617834
[TBL] [Abstract][Full Text] [Related]
11. [Expression of Notch1, Jagged1 and NICD in epithelial ovarian carcinomas and a preliminary study on the activity of gamma-secretase in epithelial ovarian carcinoma cell lines].
Feng Z; Wen H; Liao Q
Zhonghua Fu Chan Ke Za Zhi; 2014 Oct; 49(10):780-6. PubMed ID: 25537253
[TBL] [Abstract][Full Text] [Related]
12. Emodin inhibits the proliferation of PC3 prostate cancer cells in vitro via the Notch signaling pathway.
Deng G; Ju X; Meng Q; Yu ZJ; Ma LB
Mol Med Rep; 2015 Sep; 12(3):4427-4433. PubMed ID: 26081222
[TBL] [Abstract][Full Text] [Related]
13. Comparative efficacy of sunitinib versus sorafenib as first-line treatment for patients with metastatic renal cell carcinoma.
Park SJ; Lee JL; Park I; Park K; Ahn Y; Ahn JH; Lee DH; Ahn S; Song C; Hong JH; Kim CS; Ahn H
Chemotherapy; 2012; 58(6):468-74. PubMed ID: 23548259
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
